Concepedia

Author

Amanda Clarke

University College LondonORCID

Also Known As

A Clarke, A. Clarke, Amanda Clarke, Amanda E. Clarke, Clarke, A, G Scullard, H Appoyer, J Vera, M Stoeckle, Orkin, C.

118

Publications

6.4K

Citations

25

H-Index

30

Concepts

All Affiliations

University College LondonChelsea and Westminster Hospital NHS Foundation TrustUniversity Hospitals Sussex NHS Foundation TrustRoyal Sussex County HospitalBrighton and Sussex Medical School
AC

About

Amanda Clarke is an author at University College London specializing in hiv, medicine, and preventive medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

10

1.1K

2

Public Health

3

4

301

3

Epidemiology

3

4

301

4

Social Sciences

2

2

225

5

Health Policy

1

1

17

Amanda Clarke

×

46

Publications

4.9K

Citations

22

H-Index

YearCitations

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

Sheena McCormack, David Dunn, Monica Desai,

The Lancet

2015

1.9K

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Alison Rodger, Valentina Cambiano, Tina Bruun,

The Lancet

2019

966

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Kenneth H. Mayer, Jean‐Michel Molina, Melanie Thompson,

The Lancet

2020

409

Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics

Janey Sewell, Ada Miltz, Fiona Lampe,

International Journal of Drug Policy

2017

211

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

Sarah Fidler, Wolfgang Stöhr, Lucy Dorrell,

The Lancet

2020

135

Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study

Janey Sewell, Valentina Cambiano, Andrew Speakman,

International Journal of Drug Policy

2019

100

Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial

Ada Miltz, Fiona Lampe, Loraine Bacchus,

BMC Public Health

2019

93

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

Onyema Ogbuagu, Peter Ruane, Daniel Podzamczer,

The Lancet HIV

2021

88

Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013–2016

Janey Sewell, Valentina Cambiano, Ada Miltz,

Sexually Transmitted Infections

2018

87

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

François Raffi, Chloe Orkin, Amanda Clarke,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2017

83

Page 1